New registry aims to shed light on angelman syndrome
NCT ID NCT03650569
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed registry study collected information from 82 people with Angelman syndrome in Italy. The goal was to track medical and behavioral problems linked to the condition. No treatments or interventions were tested; instead, the data will help researchers better understand Angelman syndrome and potentially improve future care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this registry could help researchers better understand Angelman syndrome and improve care for those affected.
- What could go wrong
- This is an observational registry, not a treatment trial, so it will not directly lead to new therapies. Results depend on the quality of data provided by participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANGELMAN SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
FROM - Research Foundation Bergamo Hospital - ETS, Bergamo, Italy
Bergamo, 24127, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can early parent coaching help infants with rare genetic disorders thrive?
- Newborn screening study aims to catch rare diseases at birth
- New hope for angelman syndrome: drug trial targets brain function
- New study tracks angelman syndrome progression in kids and adults
- 2000-Patient study aims to uncover hidden metabolic risks in rare genetic disorders
- Can a video-based therapy tame tough behaviors in kids with rare genetic disorders?